Scandinavian ChemoTech AB (publ) 8V6.F Stock
Scandinavian ChemoTech AB (publ) Price Chart
Scandinavian ChemoTech AB (publ) 8V6.F Financial and Trading Overview
| Scandinavian ChemoTech AB (publ) stock price | 0.15 EUR |
| Previous Close | 0.32 EUR |
| Open | 0.3 EUR |
| Bid | 0.32 EUR x N/A |
| Ask | 0.4 EUR x N/A |
| Day's Range | 0.3 - 0.3 EUR |
| 52 Week Range | 0.3 - 1.08 EUR |
| Volume | 100 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 4.69M EUR |
| Beta (5Y Monthly) | 1.529118 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.08 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
8V6.F Valuation Measures
| Enterprise Value | 3.95M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Scandinavian ChemoTech AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.529118 |
| 52-Week Change | -69.42% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.08 EUR |
| 52 Week Low | 0.3 EUR |
| 50-Day Moving Average | 0.4 EUR |
| 200-Day Moving Average | 0.52 EUR |
8V6.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 12.21M |
| Float | 9.82M |
| Short Ratio | N/A |
| % Held by Insiders | 34.06% |
| % Held by Institutions | 3.57% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | -60.38% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -67.33% |
| Return on Equity (ttm) | -154.020% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | -1.79% |
| Gross Profit (ttm) | -11842000 EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.15 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.198 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Scandinavian ChemoTech AB (publ)
| Country | Germany |
| State | N/A |
| City | Lund |
| Address | Medicon Village |
| ZIP | 223 63 |
| Phone | 46 1 0218 9300 |
| Website | https://chemotech.se |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
Scandinavian ChemoTech AB (publ) offers cancer care and pain management solutions. Its product, IQWave, is an electroporation device, used for treating head and neck squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. It also offers Vetiqure, a tumor specific electroporation used for treating solid and superficial malignant tumors for animals. The company markets its products through distribution channels and a network of opinion leaders in Middle East, Asia, India, Africa, and internationally. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.
Q&A For Scandinavian ChemoTech AB (publ) Stock
What is a current 8V6.F stock price?
Scandinavian ChemoTech AB (publ) 8V6.F stock price today per share is 0.15 EUR.
How to purchase Scandinavian ChemoTech AB (publ) stock?
You can buy 8V6.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Scandinavian ChemoTech AB (publ)?
The stock symbol or ticker of Scandinavian ChemoTech AB (publ) is 8V6.F.
Which industry does the Scandinavian ChemoTech AB (publ) company belong to?
The Scandinavian ChemoTech AB (publ) industry is Biotechnology.
How many shares does Scandinavian ChemoTech AB (publ) have in circulation?
The max supply of Scandinavian ChemoTech AB (publ) shares is 23.45M.
What is Scandinavian ChemoTech AB (publ) Price to Earnings Ratio (PE Ratio)?
Scandinavian ChemoTech AB (publ) PE Ratio is now.
What was Scandinavian ChemoTech AB (publ) earnings per share over the trailing 12 months (TTM)?
Scandinavian ChemoTech AB (publ) EPS is -0.08 EUR over the trailing 12 months.
Which sector does the Scandinavian ChemoTech AB (publ) company belong to?
The Scandinavian ChemoTech AB (publ) sector is Healthcare.